Abstract The Coronavirus disease 2019 (COVID-19) pandemic has led to a surge in need for
alternative routes of administration of drugs for end of life and palliative care, particularly in …

Background: The anticipatory prescribing of injectable medications to provide end-of-life
symptom relief is an established community practice in a number of countries. The evidence …

Doctors, nurses, and family caregivers worldwide are facing tough decisions concerning the
supply and administration of medications to manage symptoms when patients are dying …

Background Anticipatory prescribing (AP) of injectable medications in advance of clinical
need is established practice in community end-of-life care. Changes to prescribing …

Home-care nurses assist many advanced cancer patients desiring to live in the familiar
surroundings of their own home until the day they die. The purpose of this study was to …

Objective: To review the administration of antidepressant and antipsychotic medications via
inhaled, intranasal, buccal, sublingual, transdermal, and rectal routes. Data Sources: A …

BACKGROUND Most people who are dying want to be cared for at home, but only half of
them achieve this. The likelihood of a home death often depends on the availability of able …

Purpose The decision-making process for medication use in the last weeks of life is complex
because of patient frailty and poor prognosis. Limited literature is available on medication …

Background While the majority of seriously ill people wish to die at home, only half achieve
this. The likelihood of someone dying at home often depends on the availability of able and …

Objectives To understand healthcare professionals' experiences of delivering anticipatory
prescribing (AP) during the first wave of the UK COVID-19 pandemic. Methods …